Abstract
We investigated gender as a factor in viral load measurements for human immunodeficiency virus-infected patients. Forty antiretroviral-therapy-naive, age- and CD4-matched women and men were tested for serum RNA and p24 antigen levels prior to antiretroviral therapy and at approximately 12 weeks after therapy. No gender differences were observed for these two markers of viral load.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antiviral Agents / therapeutic use
-
Biomarkers
-
Female
-
HIV Core Protein p24 / blood
-
HIV Infections / drug therapy
-
HIV Infections / virology*
-
HIV-1 / isolation & purification*
-
Humans
-
Male
-
Middle Aged
-
RNA, Viral / blood*
-
Sex Characteristics
-
Viremia / drug therapy
-
Viremia / virology*
Substances
-
Antiviral Agents
-
Biomarkers
-
HIV Core Protein p24
-
RNA, Viral